Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A0B6SJ / Name: PST / Stock / Construction & Engineering / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Panevezio Statybos Lt 1 Stock

Pros and Cons of Panevezio Statybos Lt 1 in the next few years

Pros
?
G***** c******* t* c**********
?
M***** P*******
?
B****
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Panevezio Statybos Lt 1 vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Panevezio Statybos Lt 1 - - - - - - -
J+p-Avax S.a. Nam. Eo 0,58 0.880% -4.500% 54.698% 117.045% 30.822% 350.472% 487.692%
Verbrec Ltd. -1.850% -4.505% 18.436% 92.727% -7.018% 61.832% -19.022%
Inypsa -2.000% -1.342% -6.170% -18.333% 5.000% 12.500% -36.910%

News

PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference
PromiCell, Inc. presents during JP Morgan's 2026 Healthcare Conference

MIAMI, FL / ACCESS Newswire / January 9, 2026 / PromiCell, Inc. (the "Company"), a clinical-stage cellular immunotherapy company uniquely positioned to advance potentially curative cell